A. Panarella
Papers
1
Total Citations
42
H-Index
1
About
A. Panarella is a researcher whose work focuses on the intersection of rare diseases and high-throughput screening technologies. Their most-cited paper, "High‐content drug screening for rare diseases" (2017, 42 citations), addresses a critical challenge in biomedical research: while individual rare diseases affect few patients, collectively they represent a significant and underserved medical burden. Panarella's major contribution lies in adapting high-content screening methodologies—typically used for common conditions—to the unique constraints of rare disease drug discovery, where limited patient populations and biological samples demand innovative approaches. This work highlights the potential of automated, image-based assays to identify therapeutic candidates for conditions that are often neglected by traditional pharmaceutical pipelines. By demonstrating that scalable screening can be applied to these orphan indications, Panarella has helped bridge the gap between fundamental rare disease biology and translational drug development. Their research underscores a commitment to tackling medical challenges that are frequently overlooked, offering a methodological blueprint for other scientists working in this space. With 42 citations, this paper has become a reference point for researchers seeking to apply high-content strategies to rare disease contexts.
Research Focus
Key Achievements
Top Papers
- 1High‐content drug screening for rare diseases42 citations · 2017